NewsRx

Search our medical news database

Hard to Treat Diseases

Hard to Treat Diseases HTDS Acquired Varicella Approval in Guatemala

Published in Vaccine Weekly, March 24th, 2010

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its subsidiary Mellow Hope announce that the company received Registration Certificate for its MEVAC-Vari vaccine in Guatemala.

This is the first Final Approval for HTDS' Varicella vaccine in South America. In general, doctors regard Varicella, commonly known as chickenpox, as a mild viral illness. However, approx. 1 in 50 cases chickenpox associates with complications such as pneumonia and encephalitis, and both diseases report high mortality rate.

A source close to HTDS said, "Varicella complications can be averted by a simple vaccination, and we are happy that we obtained the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook